Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pettinelli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|May 15, 1993
The Concorde trialS Lagakos, C Pettinelli, D Stein
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Methodological issues in AIDS clinical trials. Application of the combination index method in the design of a clinical antiretroviral trial: ACTG 068D Mildvan, R Ruprecht, S Krown, et al.
Archives of Internal Medicine|November 1, 1992
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials GroupM A Koch, P A Volberding, S W Lagakos, et al.
The Journal of Infectious Diseases|November 7, 1998
Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042J A Bartlett, C Berend, G R Petroni, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complexD Mildvan, J Buzas, D Armstrong, et al.
Annals of Internal Medicine|February 1, 1989
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II studyT C Merigan, G Skowron, S A Bozzette, et al.
Reviews of Infectious Diseases|July 1, 1990
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complexR Dolin, J S Lambert, G D Morse, et al.
Annals of Internal Medicine|July 15, 1990
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group StudyH Hochster, D Dieterich, S Bozzette, et al.
The New England Journal of Medicine|May 10, 1990
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trialJ S Lambert, M Seidlin, R C Reichman, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|May 15, 1993
The Concorde trialS Lagakos, C Pettinelli, D Stein
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Methodological issues in AIDS clinical trials. Application of the combination index method in the design of a clinical antiretroviral trial: ACTG 068D Mildvan, R Ruprecht, S Krown, et al.
Archives of Internal Medicine|November 1, 1992
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials GroupM A Koch, P A Volberding, S W Lagakos, et al.
The Journal of Infectious Diseases|November 7, 1998
Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042J A Bartlett, C Berend, G R Petroni, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complexD Mildvan, J Buzas, D Armstrong, et al.
Annals of Internal Medicine|February 1, 1989
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II studyT C Merigan, G Skowron, S A Bozzette, et al.
Reviews of Infectious Diseases|July 1, 1990
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complexR Dolin, J S Lambert, G D Morse, et al.
Annals of Internal Medicine|July 15, 1990
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group StudyH Hochster, D Dieterich, S Bozzette, et al.
The New England Journal of Medicine|May 10, 1990
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trialJ S Lambert, M Seidlin, R C Reichman, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
Pageof 2